$PODD
INSULET CORP Stock $podd

$podd Overview Financials Valuation SEC Filings Company Website

2024 Q2 Form 10-Q Financial Statement

#000114519724000022 Filed on May 10, 2024

Income Statement

Concept	2024 Q2	2024 Q1
Revenue	$488.5M	$441.7M
YoY Change	23.2%	23.35%
Cost Of Revenue	$157.6M	$134.9M
YoY Change	19.76%	14.71%
Gross Profit	$330.9M	$306.8M
YoY Change	24.92%	27.57%
Gross Profit Margin	67.74%	69.46%
Selling, General & Admin	$222.4M	$199.7M
YoY Change	24.45%	22.74%
% of Gross Profit	67.21%	65.09%
Research & Development	$53.90M	$50.20M
YoY Change	-2.18%	0.2%
% of Gross Profit	16.29%	16.36%
Depreciation & Amortization	$19.20M	$18.80M
YoY Change	6.08%	9.3%
% of Gross Profit	5.8%	6.13%
Operating Expenses	$276.3M	$249.9M
YoY Change	18.18%	17.43%
Operating Profit	$54.60M	$56.90M
YoY Change	75.56%	105.42%
Interest Expense	-$1.700M	$10.70M
YoY Change	-117.53%	13.83%
% of Operating Profit	-3.11%	18.8%
Other Income/Expense, Net	-$1.800M	-$700.0K
YoY Change	800.0%	250.0%
Pretax Income	$51.10M	$54.90M
YoY Change	79.3%	123.17%
Income Tax	-$137.5M	$3.400M
% Of Pretax Income	-269.08%	6.19%
Net Earnings	$188.6M	$51.50M
YoY Change	590.84%	116.39%
Net Earnings / Revenue	38.61%	11.66%
Basic Earnings Per Share	$2.69	$0.74
Diluted Earnings Per Share	$2.59	$0.73
COMMON SHARES
Basic Shares Outstanding	70.04M shares	69.93M shares
Diluted Shares Outstanding	73.80M shares	73.74M shares

Balance Sheet

Concept	2024 Q2	2024 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$715.5M	$696.9M
YoY Change	32.16%	34.36%
Cash & Equivalents	$821.0M	$751.2M
Short-Term Investments
Other Short-Term Assets	$253.8M	$170.4M
YoY Change	16.26%	-18.08%
Inventory	$430.9M	$430.6M
Prepaid Expenses
Receivables	$348.6M	$320.5M
Other Receivables	$0.00	$0.00
Total Short-Term Assets	$1.749B	$1.618B
YoY Change	23.02%	21.68%
LONG-TERM ASSETS
Property, Plant & Equipment	$677.9M	$667.7M
YoY Change	12.7%	11.92%
Goodwill	$51.70M	$51.70M
YoY Change	0.0%	0.0%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$163.6M	$187.7M
YoY Change	-22.68%	-10.87%
Total Long-Term Assets	$1.133B	$1.006B
YoY Change	17.47%	4.85%
TOTAL ASSETS
Total Short-Term Assets	$1.749B	$1.618B
Total Long-Term Assets	$1.133B	$1.006B
Total Assets	$2.882B	$2.624B
YoY Change	20.78%	14.63%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$76.80M	$75.90M
YoY Change	-28.56%	-11.64%
Accrued Expenses	$371.3M	$317.6M
YoY Change	36.96%	20.49%
Deferred Revenue	$21.90M	$18.20M
YoY Change	12.89%	-18.02%
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due	$37.90M	$38.90M
YoY Change	29.79%	39.93%
Total Short-Term Liabilities	$486.0M	$432.4M
YoY Change	14.35%	12.81%
LONG-TERM LIABILITIES
Long-Term Debt	$1.360B	$1.363B
YoY Change	-0.64%	-0.45%
Other Long-Term Liabilities	$37.30M	$38.30M
YoY Change	-2.61%	11.99%
Total Long-Term Liabilities	$37.30M	$38.30M
YoY Change	-97.35%	-97.27%
TOTAL LIABILITIES
Total Short-Term Liabilities	$486.0M	$432.4M
Total Long-Term Liabilities	$37.30M	$38.30M
Total Liabilities	$1.883B	$1.833B
YoY Change	2.8%	2.63%
SHAREHOLDERS EQUITY
Retained Earnings	-$137.9M	-$326.5M
YoY Change	-74.14%	-41.75%
Common Stock	$100.0K	$100.0K
YoY Change	0.0%	0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$998.4M	$790.7M
YoY Change
Total Liabilities & Shareholders Equity	$2.882B	$2.624B
YoY Change	20.78%	14.63%

Cashflow Statement

Concept	2024 Q2	2024 Q1
OPERATING ACTIVITIES
Net Income	$188.6M	$51.50M
YoY Change	590.84%	116.39%
Depreciation, Depletion And Amortization	$19.20M	$18.80M
YoY Change	6.08%	9.3%
Cash From Operating Activities	$96.50M	$87.60M
YoY Change	119.32%	17420.0%
INVESTING ACTIVITIES
Capital Expenditures	$24.90M	$22.10M
YoY Change	37.57%	110.48%
Acquisitions
YoY Change
Other Investing Activities	$0.00	$0.00
YoY Change	-100.0%	-100.0%
Cash From Investing Activities	-$24.90M	-$24.00M
YoY Change	7.79%	-42.99%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-900.0K	-$14.10M
YoY Change	-128.13%	16.53%
NET CHANGE
Cash From Operating Activities	96.50M	$87.60M
Cash From Investing Activities	-24.90M	-$24.00M
Cash From Financing Activities	-900.0K	-$14.10M
Net Change In Cash	70.70M	$47.00M
YoY Change	193.36%	-187.36%
FREE CASH FLOW
Cash From Operating Activities	$96.50M	$87.60M
Capital Expenditures	$24.90M	$22.10M
Free Cash Flow	$71.60M	$65.50M
YoY Change	176.45%	-755.0%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2024Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	70020202	shares
CY2024Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	70020202	shares
CY2023Q4	us-gaap	Finance Lease Liability Noncurrent Statement Of Financial Position Extensible List FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2023#LongTermDebtAndCapitalLeaseObligations
CY2024Q1	us-gaap	Finance Lease Liability Noncurrent Statement Of Financial Position Extensible List FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2023#LongTermDebtAndCapitalLeaseObligations
CY2023Q4	us-gaap	Derivative Asset Statement Of Financial Position Extensible Enumeration DerivativeAssetStatementOfFinancialPositionExtensibleEnumeration	http://fasb.org/us-gaap/2023#OtherAssetsNoncurrent
CY2024Q1	us-gaap	Derivative Asset Statement Of Financial Position Extensible Enumeration DerivativeAssetStatementOfFinancialPositionExtensibleEnumeration	http://fasb.org/us-gaap/2023#OtherAssetsNoncurrent
CY2024Q1	us-gaap	Other Assets Fair Value Disclosure OtherAssetsFairValueDisclosure	29400000	usd
CY2023Q4	us-gaap	Other Assets Fair Value Disclosure OtherAssetsFairValueDisclosure	31300000	usd
CY2024Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	187700000	usd
CY2023Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	190000000.0	usd
CY2024Q1	us-gaap	Assets Assets	2624000000	usd
CY2023Q4	us-gaap	Assets Assets	2588200000	usd
CY2024Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	75900000	usd
CY2023Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	19200000	usd
CY2024Q1	us-gaap	Long Term Debt Current LongTermDebtCurrent	38900000	usd
CY2023Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	49400000	usd
CY2024Q1	us-gaap	Liabilities Current LiabilitiesCurrent	432400000	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	451200000	usd
CY2024Q1	us-gaap	Long Term Debt And Capital Lease Obligations LongTermDebtAndCapitalLeaseObligations	1362600000	usd
CY2023Q4	us-gaap	Long Term Debt And Capital Lease Obligations LongTermDebtAndCapitalLeaseObligations	1366400000	usd
CY2024Q1	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	38300000	usd
CY2023Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	37900000	usd
CY2024Q1	us-gaap	Liabilities Liabilities	1833300000	usd
CY2023Q4	us-gaap	Liabilities Liabilities	1855500000	usd
CY2024Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2024Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2024Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2023Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2023Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2024Q1	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2024Q1	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2023Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2024Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2024Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	69907289	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	69907289	shares
CY2024Q1	us-gaap	Common Stock Value CommonStockValue	100000	usd
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	100000	usd
CY2024Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	1117600000	usd
CY2023Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	1102600000	usd
CY2024Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-326500000	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-378000000.0	usd
CY2024Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-500000	usd
CY2023Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	8000000.0	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	790700000	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	732700000	usd
CY2024Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	2624000000	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	2588200000	usd
CY2024Q1	us-gaap	Revenues Revenues	441700000	usd
CY2023Q1	us-gaap	Revenues Revenues	358100000	usd
CY2024Q1	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	134900000	usd
CY2023Q1	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	117600000	usd
CY2024Q1	us-gaap	Gross Profit GrossProfit	306800000	usd
CY2023Q1	us-gaap	Gross Profit GrossProfit	240500000	usd
CY2024Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	50200000	usd
CY2023Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	50100000	usd
CY2024Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	199700000	usd
CY2023Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	162700000	usd
CY2024Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	56900000	usd
CY2023Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	27700000	usd
CY2024Q1	us-gaap	Interest Expense InterestExpense	10700000	usd
CY2023Q1	us-gaap	Interest Expense InterestExpense	9400000	usd
CY2024Q1	us-gaap	Investment Income Interest InvestmentIncomeInterest	9400000	usd
CY2023Q1	us-gaap	Investment Income Interest InvestmentIncomeInterest	6500000	usd
CY2024Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-700000	usd
CY2023Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-200000	usd
CY2024Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	54900000	usd
CY2023Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	24600000	usd
CY2024Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	3400000	usd
CY2023Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	800000	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	51500000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	23800000	usd
CY2024Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.74
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.34
CY2024Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.73
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.34
CY2024Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	69957000	shares
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	69583000	shares
CY2024Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	73741000	shares
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	70096000	shares
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	51500000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	23800000	usd
CY2024Q1	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	-6600000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	1700000	usd
CY2024Q1	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax Parent OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent	-1900000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax Parent OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent	-5800000	usd
CY2024Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-8500000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-4100000	usd
CY2024Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	43000000.0	usd
CY2023Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	19700000	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	732700000	usd
CY2024Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	5800000	usd
CY2024Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	14200000	usd
CY2024Q1	us-gaap	Restricted Stock Value Shares Issued Net Of Tax Withholdings RestrictedStockValueSharesIssuedNetOfTaxWithholdings	-5000000.0	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	51500000	usd
CY2024Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-8500000	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	790700000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	476400000	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	6000000.0	usd
CY2023Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	12100000	usd
CY2023Q1	us-gaap	Restricted Stock Value Shares Issued Net Of Tax Withholdings RestrictedStockValueSharesIssuedNetOfTaxWithholdings	-11400000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	23800000	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	502800000	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	51500000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	23800000	usd
CY2024Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	18800000	usd
CY2023Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	17200000	usd
CY2024Q1	us-gaap	Share Based Compensation ShareBasedCompensation	14200000	usd
CY2023Q1	us-gaap	Share Based Compensation ShareBasedCompensation	12100000	usd
CY2024Q1	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	2000000.0	usd
CY2023Q1	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	1500000	usd
CY2024Q1	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	1200000	usd
CY2023Q1	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	1200000	usd
CY2024Q1	us-gaap	Other Operating Activities Cash Flow Statement OtherOperatingActivitiesCashFlowStatement	100000	usd
CY2023Q1	us-gaap	Other Operating Activities Cash Flow Statement OtherOperatingActivitiesCashFlowStatement	700000	usd
CY2024Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-3500000	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	19200000	usd
CY2024Q1	us-gaap	Increase Decrease In Accounts Receivable Related Parties IncreaseDecreaseInAccountsReceivableRelatedParties	-33100000	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Receivable Related Parties IncreaseDecreaseInAccountsReceivableRelatedParties	-7100000	usd
CY2024Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	29600000	usd
CY2023Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	38200000	usd
CY2024Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	400000	usd
CY2023Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	20700000	usd
CY2024Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	55500000	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	51500000	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	87600000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	500000	usd
CY2024Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	22100000	usd
CY2023Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	10500000	usd
CY2024Q1	us-gaap	Payments For Software PaymentsForSoftware	1900000	usd
CY2023Q1	us-gaap	Payments For Software PaymentsForSoftware	1500000	usd
CY2024Q1	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	0	usd
CY2023Q1	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	25100000	usd
CY2024Q1	us-gaap	Payments To Acquire Businesses Gross PaymentsToAcquireBusinessesGross	0	usd
CY2023Q1	us-gaap	Payments To Acquire Businesses Gross PaymentsToAcquireBusinessesGross	3000000.0	usd
CY2024Q1	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	0	usd
CY2023Q1	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	2000000.0	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-24000000.0	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-42100000	usd
CY2024Q1	podd	Repayment Of Equipment Financings RepaymentOfEquipmentFinancings	7200000	usd
CY2023Q1	podd	Repayment Of Equipment Financings RepaymentOfEquipmentFinancings	4800000	usd
CY2024Q1	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	5800000	usd
CY2023Q1	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	0	usd
CY2024Q1	podd	Repayments Of Term Loan RepaymentsOfTermLoan	1300000	usd
CY2023Q1	podd	Repayments Of Term Loan RepaymentsOfTermLoan	1300000	usd
CY2024Q1	podd	Repayment Of Mortgage RepaymentOfMortgage	600000	usd
CY2023Q1	podd	Repayment Of Mortgage RepaymentOfMortgage	600000	usd
CY2024Q1	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	5800000	usd
CY2023Q1	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	6000000.0	usd
CY2024Q1	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	5000000.0	usd
CY2023Q1	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	11400000	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-14100000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-12100000	usd
CY2024Q1	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-2500000	usd
CY2023Q1	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-100000	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	47000000.0	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-53800000	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	704200000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	689700000	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	751200000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	635900000	usd
CY2024Q1	us-gaap	Revenues Revenues	441700000	usd
CY2023Q1	us-gaap	Revenues Revenues	358100000	usd
CY2024Q1	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	18200000	usd
CY2023Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	15400000	usd
CY2024Q1	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	2000000.0	usd
CY2023Q4	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	1900000	usd
CY2024Q1	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	20200000	usd
CY2023Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	17300000	usd
CY2024Q1	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	3100000	usd
CY2023Q1	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	9900000	usd
CY2024Q1	us-gaap	Capitalized Contract Cost Net Current CapitalizedContractCostNetCurrent	16800000	usd
CY2023Q4	us-gaap	Capitalized Contract Cost Net Current CapitalizedContractCostNetCurrent	16600000	usd
CY2024Q1	us-gaap	Capitalized Contract Cost Net Noncurrent CapitalizedContractCostNetNoncurrent	32100000	usd
CY2023Q4	us-gaap	Capitalized Contract Cost Net Noncurrent CapitalizedContractCostNetNoncurrent	32000000.0	usd
CY2024Q1	us-gaap	Capitalized Contract Cost Net CapitalizedContractCostNet	48900000	usd
CY2023Q4	us-gaap	Capitalized Contract Cost Net CapitalizedContractCostNet	48600000	usd
CY2024Q1	us-gaap	Capitalized Contract Cost Amortization CapitalizedContractCostAmortization	4200000	usd
CY2023Q1	us-gaap	Capitalized Contract Cost Amortization CapitalizedContractCostAmortization	4000000	usd
CY2023Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	2500000	usd
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	2500000	usd
CY2024Q1	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	1200000	usd
CY2023Q1	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	1200000	usd
CY2024Q1	us-gaap	Allowance For Doubtful Accounts Receivable Write Offs AllowanceForDoubtfulAccountsReceivableWriteOffs	200000	usd
CY2023Q1	us-gaap	Allowance For Doubtful Accounts Receivable Write Offs AllowanceForDoubtfulAccountsReceivableWriteOffs	700000	usd
CY2024Q1	us-gaap	Allowance For Doubtful Accounts Receivable Recoveries AllowanceForDoubtfulAccountsReceivableRecoveries	0	usd
CY2023Q1	us-gaap	Allowance For Doubtful Accounts Receivable Recoveries AllowanceForDoubtfulAccountsReceivableRecoveries	100000	usd
CY2024Q1	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	3500000	usd
CY2023Q1	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	3100000	usd
CY2024Q1	us-gaap	Inventory Raw Materials InventoryRawMaterials	146500000	usd
CY2023Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	118200000	usd
CY2024Q1	us-gaap	Inventory Work In Process InventoryWorkInProcess	64000000.0	usd
CY2023Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	60600000	usd
CY2024Q1	us-gaap	Inventory Finished Goods InventoryFinishedGoods	220100000	usd
CY2023Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	223800000	usd
CY2024Q1	us-gaap	Inventory Net InventoryNet	430600000	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	402600000	usd
CY2024Q1	podd	Excess And Obsolete Inventory Charge ExcessAndObsoleteInventoryCharge	2600000	usd
CY2023Q1	podd	Excess And Obsolete Inventory Charge ExcessAndObsoleteInventoryCharge	2200000	usd
CY2024Q1	podd	Capitalized Computer Software Gross Current CapitalizedComputerSoftwareGrossCurrent	27100000	usd
CY2023Q4	podd	Capitalized Computer Software Gross Current CapitalizedComputerSoftwareGrossCurrent	26400000	usd
CY2024Q1	podd	Capitalized Computer Software Gross Noncurrent CapitalizedComputerSoftwareGrossNoncurrent	122300000	usd
CY2023Q4	podd	Capitalized Computer Software Gross Noncurrent CapitalizedComputerSoftwareGrossNoncurrent	116900000	usd
CY2024Q1	us-gaap	Capitalized Computer Software Gross CapitalizedComputerSoftwareGross	149400000	usd
CY2023Q4	us-gaap	Capitalized Computer Software Gross CapitalizedComputerSoftwareGross	143300000	usd
CY2024Q1	us-gaap	Capitalized Computer Software Accumulated Amortization CapitalizedComputerSoftwareAccumulatedAmortization	42700000	usd
CY2023Q4	us-gaap	Capitalized Computer Software Accumulated Amortization CapitalizedComputerSoftwareAccumulatedAmortization	36600000	usd
CY2024Q1	us-gaap	Capitalized Computer Software Net CapitalizedComputerSoftwareNet	106700000	usd
CY2023Q4	us-gaap	Capitalized Computer Software Net CapitalizedComputerSoftwareNet	106700000	usd
CY2024Q1	us-gaap	Capitalized Computer Software Amortization1 CapitalizedComputerSoftwareAmortization1	6100000	usd
CY2023Q1	us-gaap	Capitalized Computer Software Amortization1 CapitalizedComputerSoftwareAmortization1	4300000	usd
CY2023Q4	us-gaap	Goodwill Goodwill	51700000	usd
CY2024Q1	us-gaap	Goodwill Goodwill	51700000	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	152100000	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	53600000	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	98500000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	149900000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	51200000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	98700000	usd
CY2024Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	2400000	usd
CY2023Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	2400000	usd
CY2023Q4	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	5000000	usd
CY2024Q1	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	5000000	usd
CY2023Q4	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	5000000	usd
CY2024Q1	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	5000000	usd
CY2024Q1	us-gaap	Other Investments OtherInvestments	2000000	usd
CY2023Q4	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	10300000	usd
CY2022Q4	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	62100000	usd
CY2024Q1	us-gaap	Product Warranty Accrual Warranties Issued ProductWarrantyAccrualWarrantiesIssued	5500000	usd
CY2023Q1	us-gaap	Product Warranty Accrual Warranties Issued ProductWarrantyAccrualWarrantiesIssued	5500000	usd
CY2024Q1	us-gaap	Product Warranty Accrual Preexisting Increase Decrease ProductWarrantyAccrualPreexistingIncreaseDecrease	0	usd
CY2023Q1	us-gaap	Product Warranty Accrual Preexisting Increase Decrease ProductWarrantyAccrualPreexistingIncreaseDecrease	-8000000.0	usd
CY2024Q1	us-gaap	Product Warranty Accrual Payments ProductWarrantyAccrualPayments	4500000	usd
CY2023Q1	us-gaap	Product Warranty Accrual Payments ProductWarrantyAccrualPayments	20400000	usd
CY2024Q1	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	11300000	usd
CY2023Q1	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	39200000	usd
CY2022Q4	podd	Number Of Voluntary Medical Device Correction Notices Issued NumberOfVoluntaryMedicalDeviceCorrectionNoticesIssued	2	notice
CY2023Q1	us-gaap	Product Warranty Accrual Preexisting Increase Decrease ProductWarrantyAccrualPreexistingIncreaseDecrease	-8000000	usd
CY2024Q1	podd	Standard And Extended Product Warranty Accrual Related To Medical Device Correction Notices StandardAndExtendedProductWarrantyAccrualRelatedToMedicalDeviceCorrectionNotices	400000	usd
CY2023Q4	podd	Standard And Extended Product Warranty Accrual Related To Medical Device Correction Notices StandardAndExtendedProductWarrantyAccrualRelatedToMedicalDeviceCorrectionNotices	700000	usd
CY2024Q1	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	16300000	usd
CY2023Q4	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	22900000	usd
CY2024Q1	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	6000000.0	usd
CY2023Q4	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	6400000	usd
CY2024Q1	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	10100000	usd
CY2023Q4	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	11100000	usd
CY2024Q1	us-gaap	Long Term Debt And Capital Lease Obligations Including Current Maturities LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities	1401500000	usd
CY2023Q4	us-gaap	Long Term Debt And Capital Lease Obligations Including Current Maturities LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities	1415800000	usd
CY2024Q1	us-gaap	Long Term Debt And Capital Lease Obligations Current LongTermDebtAndCapitalLeaseObligationsCurrent	38900000	usd
CY2023Q4	us-gaap	Long Term Debt And Capital Lease Obligations Current LongTermDebtAndCapitalLeaseObligationsCurrent	49400000	usd
CY2024Q1	us-gaap	Long Term Debt And Capital Lease Obligations LongTermDebtAndCapitalLeaseObligations	1362600000	usd
CY2023Q4	us-gaap	Long Term Debt And Capital Lease Obligations LongTermDebtAndCapitalLeaseObligations	1366400000	usd
CY2024Q1	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	16300000	usd
CY2023Q4	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	22900000	usd
CY2024Q1	us-gaap	Other Investments OtherInvestments	2000000	usd
CY2024Q1	us-gaap	Equity Securities Without Readily Determinable Fair Value Amount EquitySecuritiesWithoutReadilyDeterminableFairValueAmount	9700000	usd
CY2023Q4	us-gaap	Equity Securities Without Readily Determinable Fair Value Amount EquitySecuritiesWithoutReadilyDeterminableFairValueAmount	9700000	usd
CY2024Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	14200000	usd
CY2023Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	12100000	usd
CY2024Q1	us-gaap	Oci Before Reclassifications Net Of Tax Attributable To Parent OciBeforeReclassificationsNetOfTaxAttributableToParent	-15100000	usd
CY2024Q1	us-gaap	Reclassification From Aoci Current Period Net Of Tax Attributable To Parent ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent	-6600000	usd
CY2023Q1	us-gaap	Oci Before Reclassifications Net Of Tax Attributable To Parent OciBeforeReclassificationsNetOfTaxAttributableToParent	300000	usd
CY2023Q1	us-gaap	Reclassification From Aoci Current Period Net Of Tax Attributable To Parent ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent	4400000	usd
CY2024Q1	us-gaap	Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate	0.062
CY2023Q1	us-gaap	Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate	0.034
CY2024Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	51500000	usd
CY2023Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	23800000	usd
CY2024Q1	us-gaap	Interest On Convertible Debt Net Of Tax InterestOnConvertibleDebtNetOfTax	2600000	usd
CY2023Q1	us-gaap	Interest On Convertible Debt Net Of Tax InterestOnConvertibleDebtNetOfTax	0	usd
CY2024Q1	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	54100000	usd
CY2023Q1	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	23800000	usd
CY2024Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	69957000	shares
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	69583000	shares
CY2024Q1	us-gaap	Incremental Common Shares Attributable To Conversion Of Debt Securities IncrementalCommonSharesAttributableToConversionOfDebtSecurities	3528000	shares
CY2023Q1	us-gaap	Incremental Common Shares Attributable To Conversion Of Debt Securities IncrementalCommonSharesAttributableToConversionOfDebtSecurities	0	shares
CY2024Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	73741000	shares
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	70096000	shares
CY2024Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.74
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.34
CY2024Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.73
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.34
CY2024Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	672000	shares
CY2023Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	3921000	shares
CY2024Q1	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2024Q1	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2024Q1	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false
CY2024Q1	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false

Files In Submission

Name	View Source	Status
0001145197-24-000022-index-headers.html	Edgar Link	pending
0001145197-24-000022-index.html	Edgar Link	pending
0001145197-24-000022.txt	Edgar Link	pending
0001145197-24-000022-xbrl.zip	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
podd-20240331.htm	Edgar Link	pending
podd-20240331.xsd	Edgar Link	pending
podd-exx101x2024x03x31_10q.htm	Edgar Link	pending
podd-exx311x2024x03x31_10q.htm	Edgar Link	pending
podd-exx312x2024x03x31_10q.htm	Edgar Link	pending
podd-exx321x2024x03x31_10q.htm	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
podd-20240331_def.xml	Edgar Link	unprocessable
podd-20240331_lab.xml	Edgar Link	unprocessable
podd-20240331_pre.xml	Edgar Link	unprocessable
podd-20240331_htm.xml	Edgar Link	completed
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
podd-20240331_cal.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$PODD
INSULET CORP Stock $podd

2024 Q2 Form 10-Q Financial Statement

#000114519724000022 Filed on May 10, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$PODD INSULET CORP Stock $podd

2024 Q2 Form 10-Q Financial Statement

#000114519724000022 Filed on May 10, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$PODD
INSULET CORP Stock $podd